Correll CU - Search Results

1

Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.

Hirota T, Schwartz S, Correll CU. Hirota T, et al. Among authors: correll cu. J Am Acad Child Adolesc Psychiatry. 2014 Feb;53(2):153-73. doi: 10.1016/j.jaac.2013.11.009. Epub 2013 Dec 6. J Am Acad Child Adolesc Psychiatry. 2014. PMID: 24472251 Review.

2

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM. Leucht S, et al. Am J Psychiatry. 2003 Jul;160(7):1209-22. doi: 10.1176/appi.ajp.160.7.1209. Am J Psychiatry. 2003. PMID: 12832232 Review.

3

Early prediction of antipsychotic response in schizophrenia.

Correll CU, Malhotra AK, Kaushik S, McMeniman M, Kane JM. Correll CU, et al. Am J Psychiatry. 2003 Nov;160(11):2063-5. doi: 10.1176/appi.ajp.160.11.2063. Am J Psychiatry. 2003. PMID: 14594760

4

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Correll CU, Leucht S, Kane JM. Correll CU, et al. Am J Psychiatry. 2004 Mar;161(3):414-25. doi: 10.1176/appi.ajp.161.3.414. Am J Psychiatry. 2004. PMID: 14992963 Review.

5

Metabolic effects of treatment with atypical antipsychotics.

Kane JM, Barrett EJ, Casey DE, Correll CU, Gelenberg AJ, Klein S, Newcomer JW. Kane JM, et al. Among authors: correll cu. J Clin Psychiatry. 2004 Nov;65(11):1447-55. doi: 10.4088/jcp.v65n1102. J Clin Psychiatry. 2004. PMID: 15554755 No abstract available.

6

A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents.

Saito E, Correll CU, Gallelli K, McMeniman M, Parikh UH, Malhotra AK, Kafantaris V. Saito E, et al. Among authors: correll cu. J Child Adolesc Psychopharmacol. 2004 Fall;14(3):350-8. doi: 10.1089/cap.2004.14.350. J Child Adolesc Psychopharmacol. 2004. PMID: 15650492 Review.

7

Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications.

Straker D, Correll CU, Kramer-Ginsberg E, Abdulhamid N, Koshy F, Rubens E, Saint-Vil R, Kane JM, Manu P. Straker D, et al. Among authors: correll cu. Am J Psychiatry. 2005 Jun;162(6):1217-21. doi: 10.1176/appi.ajp.162.6.1217. Am J Psychiatry. 2005. PMID: 15930076

8

Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome.

Correll CU, Lencz T, Smith CW, Auther AM, Nakayama EY, Hovey L, Olsen R, Shah M, Foley C, Cornblatt BA. Correll CU, et al. J Child Adolesc Psychopharmacol. 2005 Jun;15(3):418-33. doi: 10.1089/cap.2005.15.418. J Child Adolesc Psychopharmacol. 2005. PMID: 16092908

9

Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?

Correll CU. Correll CU. J Clin Psychiatry. 2005 Oct;66(10):1331-2. doi: 10.4088/jcp.v66n1018. J Clin Psychiatry. 2005. PMID: 16259549 No abstract available.

10

Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.

Correll CU, Penzner JB, Parikh UH, Mughal T, Javed T, Carbon M, Malhotra AK. Correll CU, et al. Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):177-206. doi: 10.1016/j.chc.2005.08.007. Child Adolesc Psychiatr Clin N Am. 2006. PMID: 16321730 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results